Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-030839
Filing Date
2021-07-30
Accepted
2021-07-30 17:05:20
Documents
1
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4110
  Complete submission text file 0000899243-21-030839.txt   5490
Mailing Address C/O FLAGSHIP PIONEERING, INC. 55 CAMBRIDGE PARKWAY, SUITE 800E CAMBRIDGE MA 02142
Business Address
AFEYAN NOUBAR (Reporting) CIK: 0001222012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40657 | Film No.: 211133412

Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)